Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

--Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables testing of the effects of latozinemab in frontotemporal dementia with a progranulin gene ...

GlaxoSmithKline is under pressure from shareholders to rein in pay for its incoming chief executive, Emma Walmsley, according to reports. Walmsley is set to take over from Sir Andrew Witty when he ...